2008-07-17 06:00:00
LAVAL, Quebec–(EMWNews)–The Board of Directors of Neptune Technologies & Bioressources Inc.
(NASDAQ:NEPT)(TSX VENTURE:NTB) has declared a dividend distribution to
its shareholders.
Neptune’s Board of Directors approved a
dividend of $ 0.00025 CDN per share on the outstanding common shares of
the Corporation for payment to shareholders of record at the close of
business on July 28, 2008. This dividend will be payable on or around
August 11, 2008 by the issuance of non-convertible notes, with a two
year maturity, bearing interest from the first anniversary date of their
issuance at a rate of ten percent (10%) per annum, and being redeemable
by the obligor at any time, by advance payment, either in cash or in
kind, including in equity securities of the obligor of such notes.
About Neptune
Neptune researches and develops proprietary bioactive ingredients and
products for nutraceutical, medical food and pharmaceutical
applications. Through clinical research, Neptune is showing the clinical
benefits of its products in various therapeutic indications with a focus
on cardiovascular and cognitive health. The Company has been successful
in patenting and protecting its intellectual property, and will continue
to protect its innovations. Neptune has already obtained regulatory
approvals allowing commercialization of its products and has filed for
and is expecting additional approvals.
Neptune continues to strongly support its strategic development plan to
form partnerships/strategic alliances with worldwide leaders in the
nutraceutical and pharmaceutical industries. Neptune signed agreements
with Nestlé and Yoplait, worldwide leading
food manufacturers, and paved its entrance into the global functional
food market. According to its business strategy, negotiations with
pharmaceutical companies with the objective of entering the
pharmaceutical market by licensing rights are ongoing.
Neither NASDAQ nor TSX venture exchange accepts responsibility for the
adequacy or accuracy of this press release.
Statements in this press release that are not statements of
historical or current fact constitute “forward-looking statements”
within the meaning of the U.S. Private Securities Litigation Reform Act
of 1995 and Canadian securities laws. Such forward-looking statements
involve known and unknown risks, uncertainties, and other unknown
factors that could cause the actual results of the Company to be
materially different from historical results or from any future results
expressed or implied by such forward-looking statements. In addition to
statements which explicitly describe such risks and uncertainties,
readers are urged to consider statements labeled with the terms
“believes,” “belief,” “expects,” “intends,” “anticipates,” “will,” or
“plans” to be uncertain and forward-looking. The forward-looking
statements contained herein are also subject generally to other risks
and uncertainties that are described from time to time in the Company’s
reports filed with the Securities and Exchange Commission and the
Canadian securities commissions.
|
Neptune Technologies & Bioressources Inc. Ph.D., MBA |
|
Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89
Get Unlimited Organic Website Traffic to your Website
TheNFG.com now offers Organic Lead Generation & Traffic Solutions
